Orexigen (OREX), Arena (ARNA) Stronger into Qnexa PDUFA
Tweet
Share
E-mail
Get Alerts OREX Hot Sheet
Join SI Premium – FREE
Orexigen Therapeutics (Nasdaq: OREX) is up again in early trading Monday. Shares have been volatile heading into the PDUFA date for peer VIVUS' (Nasdaq: VVUS) Qnexa obesity drug.
Volatility today is up 4.3 percent from last Friday's close.
Shares are 3.7 percent better at the start.
VIVUS PDUFA date is set for tomorrow, July 17th.
Both VIVUS and Arena Pharma (Nasdaq: ARNA) are also higher on the session so far.
Volatility today is up 4.3 percent from last Friday's close.
Shares are 3.7 percent better at the start.
VIVUS PDUFA date is set for tomorrow, July 17th.
Both VIVUS and Arena Pharma (Nasdaq: ARNA) are also higher on the session so far.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab
- Fiserv (FI) option IV elevated into quarter results and outlook
- Tesla (TSLA) erases gains, drops to $140 again
Create E-mail Alert Related Categories
FDA, Options, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
